Regulation of vascular permeability by sphingosine 1-phosphate

A significant and sustained increase in vascular permeability is a hallmark of acute inflammatory diseases such as acute lung injury (ALI) and sepsis and is an essential component of tumor metastasis, angiogenesis, and atherosclerosis. Sphingosine 1-phosphate (S1P), an endogenous bioactive lipid pro...

Full description

Saved in:
Bibliographic Details
Published in:Microvascular research 2009-01, Vol.77 (1), p.39-45
Main Authors: Wang, Lichun, Dudek, Steven M.
Format: Article
Language:English
Subjects:
Actin cytoskeleton
Acute Lung Injury - drug therapy
Adherens junction
Animals
Capillary Permeability - physiology
Cytoskeleton - physiology
Focal adhesion
Focal Adhesions - physiology
G-protein coupled receptor (GPCR)
Humans
Intercellular Junctions - physiology
Lysophospholipids - physiology
Lysophospholipids - therapeutic use
Models, Biological
Rac GTPase
Signal Transduction - physiology
Sphingosine - analogs & derivatives
Sphingosine - physiology
Sphingosine - therapeutic use
Sphingosine 1-phosphate (S1P)
Sphingosine 1-phosphate receptor 1 (S1P 1)
Tight junction
Vascular permeability
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A significant and sustained increase in vascular permeability is a hallmark of acute inflammatory diseases such as acute lung injury (ALI) and sepsis and is an essential component of tumor metastasis, angiogenesis, and atherosclerosis. Sphingosine 1-phosphate (S1P), an endogenous bioactive lipid produced in many cell types, regulates endothelial barrier function by activation of its G-protein coupled receptor S1P 1. S1P enhances vascular barrier function through a series of profound events initiated by S1P 1 ligation with subsequent downstream activation of the Rho family of small GTPases, cytoskeletal reorganization, adherens junction and tight junction assembly, and focal adhesion formation. Furthermore, recent studies have identified transactivation of S1P 1 signaling by other barrier-enhancing agents as a common mechanism for promoting endothelial barrier function. This review summarizes the state of our current knowledge about the mechanisms through which the S1P/S1P 1 axis reduces vascular permeability, which remains an area of active investigation that will hopefully produce novel therapeutic agents in the near future.
ISSN:0026-2862
1095-9319
DOI:10.1016/j.mvr.2008.09.005